<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04460144</url>
  </required_header>
  <id_info>
    <org_study_id>APHP190930</org_study_id>
    <secondary_id>IDRCB 2019-A02427-50</secondary_id>
    <nct_id>NCT04460144</nct_id>
  </id_info>
  <brief_title>Rapid Diagnostic Test for Septic Arthritis</brief_title>
  <acronym>TDR-Arthrite</acronym>
  <official_title>Diagnostic Validation Study of a Test Based on the Analysis of the Proteome by Mass Spectrometry for the Diagnosis of Septic Arthritis in Children Under 16 Years of Age.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diagnostic Validation Study of a Test Based on the Analysis of the Proteome by Mass&#xD;
      Spectrometry for the Diagnosis of Septic Arthritis in Children Under 16 Years of Age&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Arthritis is an inflammation of the joints that can have many causes. In children, septic&#xD;
      arthritis (SA) is the most common cause of acute arthritis (around 45% of cases). Juvenile&#xD;
      Idiopathic Arthritis (JIA) is a disease characterized the presence of arthritis in one or&#xD;
      more of unknown origin in children under 16 years of age, lasting more than 6 weeks. It is&#xD;
      the most common pediatric rheumatological disease with a prevalence of 16 to 150 cases per&#xD;
      100,000 children. Finally, in approximately 40% of children the origin of acute arthritis&#xD;
      remains undetermined (ND arthritis). In this group, all the examinations performed are not in&#xD;
      favor of a bacterial origin and the evolution of arthritis do not allow the diagnosis of JIA&#xD;
      to be retained and no other disease is found.&#xD;
&#xD;
      During the first few days of arthritis, differentiation between AS and non-septic arthritis&#xD;
      is difficult. The available clinical and biological parameters do not allow for easy and&#xD;
      rapid differentiation between AS and non-septic arthritis.&#xD;
&#xD;
      This project aims to develop a new diagnostic technique based on molecular analysis of the&#xD;
      proteome in the joint puncture fluid.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 6, 2021</start_date>
  <completion_date type="Anticipated">December 6, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 6, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mass spectrometry profile</measure>
    <time_frame>15 months</time_frame>
    <description>Proteomics</description>
  </primary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Juvenile Idiopathic Arthritis</condition>
  <condition>Arthritis, Septic</condition>
  <condition>Arthritis, Unspecified</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Mass spectrometry</intervention_name>
    <description>Proteomic analysis</description>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      synovial fluid blood sample stool sample nasal swab&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with acute arthritis&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients &gt;3 months of age &lt;16 years of age&#xD;
&#xD;
          -  Hospitalized for arthritis that started less than 6 weeks ago or patients with&#xD;
             diagnosed inflammatory arthritis whose clinical course suggests bacterial&#xD;
             superinfection&#xD;
&#xD;
          -  Indication of a joint puncture for diagnostic purposes, confirmed by a senior&#xD;
             physician after study of all available clinical and biological elements.&#xD;
&#xD;
          -  Holders of parental authority who have accepted the participation of their children&#xD;
&#xD;
          -  Patients benefiting from a social security scheme (excluding AME)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contraindications to joint puncture&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Months</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ulrich MEINZER, MD-PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>APHP</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stephane BONACORSI, MD-PhD</last_name>
    <role>Study Director</role>
    <affiliation>APHP</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ulrich MEINZER, MD-PhD</last_name>
    <phone>+331.40.03.20.48</phone>
    <email>ulrich.meinzer@aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stephane BONACORSI, MD-PhD</last_name>
    <phone>+331 40 03 33 75</phone>
    <email>stephane.bonacorsi@aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Robert Debre Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ulrich Meinzer, MD</last_name>
      <phone>+33140032599</phone>
      <email>ulrich.meinzer@aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 1, 2020</study_first_submitted>
  <study_first_submitted_qc>July 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 7, 2020</study_first_posted>
  <last_update_submitted>October 1, 2021</last_update_submitted>
  <last_update_submitted_qc>October 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis, Infectious</mesh_term>
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Juvenile</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

